Image source: Shutterstock

Highlights

  • USANA stock jumps 16% after surpassing Q1 earnings expectations.

  • Quarterly EPS of $0.73 beats consensus by $0.03; revenue reaches $249.54 million.

  • Insiders sell over 15,000 shares amid positive earnings momentum.

USANA Health Sciences, Inc. (NYSE:USNA) released stronger-than-expected quarterly earnings. The health and wellness company reported first-quarter earnings per share (EPS) of $0.73, surpassing analysts’ consensus forecast of $0.70. Revenue also outpaced expectations, coming in at $249.54 million against estimates of $243.08 million. However, year-over-year performance saw a dip, with USANA earning $0.86 per share in the same quarter last year.

USANA continues to maintain solid profitability metrics, posting a net margin of 6.30% and a return on equity (ROE) of 10.64%. These indicators reflect ongoing operational efficiency, even in the face of a challenging macroeconomic environment.

Analyst Sentiment Mixed

Analysts have shown mixed reactions in recent weeks. StockNews.com downgraded USANA from a “strong-buy” to a “buy” rating in mid-February. Similarly, Sidoti moved its rating from “strong-buy” to “hold.” Meanwhile, DA Davidson maintained a “neutral” stance, lowering its price target from $38.00 to $36.00.

Insider Sales Highlight Shifting Positions

Notably, insider activity has picked up. On March 10, senior executive David Mulham sold 3,234 shares at an average price of $32.98, amounting to a total transaction of over $106,000. The sale reduced his ownership in the company by approximately 20.2%.

Earlier in the month, CEO Jim Brown also divested 5,000 shares at an average price of $29.47, totaling around $147,350. This move represents a 24.14% reduction in his stake. Combined, insiders have sold 15,920 shares worth over $500,000 in the past 90 days.